General practitioners' views and experiences of over-the-counter simvastatin in Scotland

British Journal of Clinical Pharmacology

Volumn 70, Issue 3, 2010, Pages 356-359

  Stewart, Derek ^a   Cunningham, I T Scott ^a   Hansford, Denise ^a   John, Dai ^b   McCaig, Dorothy ^a   McLay, James ^c  

^a ROBERT GORDON UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c Section of Translational Medical Sciences   (United Kingdom)

Author keywords

Cardiovascular risk assessment; General practice; Scotland; Simvastatin

Indexed keywords

CHOLESTEROL; LIPID; NON PRESCRIPTION DRUG; SIMVASTATIN;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MEDICAL PRACTICE; OUTCOME ASSESSMENT; PHARMACIST; PHARMACY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SECONDARY PREVENTION; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

ATTITUDE OF HEALTH PERSONNEL; GENERAL PRACTITIONERS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NONPRESCRIPTION DRUGS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RISK ASSESSMENT; SCOTLAND; SIMVASTATIN;

EID: 77955762245     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03701.x     Document Type: Article

References (10)

1. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R on behalf of the Cholesterol Treatment Trialists' Collaborators. Efficacy and safety of cholesterol-lowering treatment prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005 366 : 1267 1278.
2. Medicines and Healthcare Products Regulatory Agency. Reclassification summary for simvastatin POM to P. 2004. Available at http://medicines.mhra-gov. uk (last accessed 10 March 2009).
3. Johnson & Johnson MSD Consumer Pharmaceuticals. Zocor Heart-Pro Pharmacist Training Guide. 2004.
4. Royal Pharmaceutical Society of Great Britain. Practice guidance: OTC simvastatin 10 mg. Pharm J 2004 273 : 169 170.
5. Medicines and Healthcare Products Regulatory Agency. Responses to ARM18: request to reclassify simvastatin 10 mg. 2003. Available at http://medicines. mhra-gov.uk (last accessed 10 March 2009).
6. Bayliss E, Rutter P. General practitioners' views on recent and proposed switches from POM to P. Pharm J 2004 273 : 819 821.
7. Anonymous. Editorial. Over-the-counter simvastatin given the go-ahead. Pharm J 2004 272 : 595.
8. Gibson L. Moves to sell statins over the counter raises concerns. Br Med J 2004 328 : 1221.
9. Anonymous. Editorial. OTC Statins: a bad decision for public health. Lancet 2004 363 : 9422.
10. Hansford D, Cunningham S, John D, McCaig D, Stewart D. Community pharmacists' views, attitudes and early experiences of over-the-counter simvastatin. Pharm World Sci 2007 29 : 380 385.